SynthesisThe Cochrane database of systematic reviews2021

Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis.

Takayoshi Kanie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.